N E W S & A N A LY S I S BIOBUSINESS BRIEFS T R I A L WAT C H
Next-generation antimalarial from phenotypic screen shows clinical promise parasite clearance time was 12 hours in each cohort, with a median parasite half-life of 0.95 hours. By comparison,
Next-generation antimalarial from phenotypic screen shows clinical promise parasite clearance time was 12 hours in each cohort, with a median parasite half-life of 0.95 hours. By comparison,
